Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 21-30 of 152

Page
per page
  1. CEP-32496
    A1413 CEP-32496
    Summary: BRAF(V600E)inhibitor,highly potent
      ≥25.85 mg/mL
  2. FR 180204
    A8304 FR 180204
    Target: ERK
    Summary: ERK inhibitor
      insoluble in H2O; ≥10.25 mg/mL
  3. PH-797804
    A8308 PH-797804
     1 Citation
    Summary: P38 MAP kinase inhibitor, potent and selective
      ≥23.85 mg/mL
  4. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL
  5. AZ 628
    A8371 AZ 628
    Summary: Raf kinases,potent and ATP-competitive
      ≥22.6 mg/mL
  6. AZD8330
    A8374 AZD8330
    Target: MEK
    Summary: MEK 1/2 inhibitor
      ≥23.05 mg/mL
  7. Furosemide
    A8435 Furosemide
    Target: Na /K /Cl- Symporters (NKCCs)|GABAA Receptors
    Summary: GABAA receptors antagonist
  8. ZM336372
    A8545 ZM336372
    Summary: C-Raf inhibitor, potent and selective
      insoluble in EtOH; insoluble in H2O; ≥19.45 mg/mL
  9. VX-745
    A8686 VX-745
    Target: p38
    Summary: P38α inhibitor,highly potent and selective
      ≥21.8 mg/mL
  10. VX-702
    A8687 VX-702
    Summary: P38α MAPK inhibitor,highly selective and ATP-competitive
      insoluble in H2O; ≥20.2 mg/mL

Items 21-30 of 152

Page
per page